Nonvalvular atrial fibrillation (NVAF) significantly elevates the risk of mortality and stroke. Despite established guidelines advocating for anticoagulation therapy in patients at high stroke risk, a substantial number of individuals either do not receive or fail to adhere to these recommended treatments. Join us as cardiology and primary care experts explore the latest NVAF guidelines and clinical evidence, with a particular focus on patient characteristics and associated health conditions. The discussion will also cover vital recommendations for lifestyle and risk factor modifications aimed at improving patient outcomes. By understanding these elements, healthcare providers can more effectively identify at-risk patients and implement targeted interventions that align with current best practices to mitigate stroke risk.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/optimizing-management-nonvalvular-atrial-fibrillation-evidence-based
- Start Date: 2024-11-18 06:00:00
- End Date: 2024-11-18 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 30000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all